NAT1 genetic variation increases asthma risk in children with secondhand smoke exposure

References

• Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention; 2006.
   Google Scholar
• Moritsugu KP. The 2006 report of the surgeon general: the health consequences of involuntary exposure to tobacco smoke. Am J Prev Med. 2007;32(6):542–543. doi:10.1016/j.amepre.2007.02.026.
   PubMed Web of Science ®Google Scholar
• NTP (National Toxicology Program). Report on carcinogens. 13th ed. Research Triangle Park (NC): Department of Health and Human Services; 2014.
   Google Scholar
• ACS. Secondhand smoke and children fact sheet. Atlanta (GA): American Cancer Society; 2006.
   Google Scholar
• Schuster MA, Franke T, Pham CB. Smoking patterns of household members and visitors in homes with children in the United States. Arch Pediatr Adolesc Med. 2002;156(11):1094–1100.
   PubMedGoogle Scholar
• Benowitz NL, Hukkanen J, Jacob P. 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;(192):29–60.
   PubMedGoogle Scholar
• Benowitz NL, Jacob P. 3rd. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56(5):483–493.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P. 3rd Individual differences in nicotine kinetics and metabolism in humans. NIDA Res Monogr. 1997;173:48–64.
   PubMedGoogle Scholar
• Benowitz NL, Perez-Stable EJ, Herrera B, Jacob P. 3rd. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst. 2002;94(2):108–115.
   PubMedGoogle Scholar
• Perez-Stable EJ, Herrera B, Jacob P, 3rd, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152–156.
   PubMed Web of Science ®Google Scholar
• Mwenifumbo JC, Tyndale RF. Molecular genetics of nicotine metabolism. Handb Exp Pharmacol. 2009;(192):235–259.
   PubMedGoogle Scholar
• LeMasters GK, Khurana Hershey GK, Sivaprasad U, Martin LJ, Pilipenko V, Ericksen MB, Burkle JW, Lindsey MA, Bernstein DI, Lockey JE, et al. N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort. Pharmacogenomics J. 2015;15(2):189–195. PubMed PMID: 25156213; doi:10.1038/tpj.2014.44.
   PubMed Web of Science ®Google Scholar
• Sim E, Walters K, Boukouvala S. Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev. 2008;40(3):479–510.. doi:10.1080/03602530802186603.
   PubMed Web of Science ®Google Scholar
• Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000;9(1):29–42.
   PubMed Web of Science ®Google Scholar
• Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res. 2002;506-507:65–77.
   PubMed Web of Science ®Google Scholar
• Khlifi R, Messaoud O, Rebai A, Hamza-Chaffai A. Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers. Biomed Res Int. 2013;2013:1. doi:10.1155/2013/582768.
   Web of Science ®Google Scholar
• Briggs FBS, Acuna B, Shen L, Ramsay P, Quach H, Bernstein A, Bellesis KH, Kockum IS, Hedström AK, Alfredsson L, et al. Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants. Epidemiology. 2014;25(4):605–614. doi:10.1097/EDE.0000000000000089.
   PubMed Web of Science ®Google Scholar
• Sorensen M, Autrup H, Olsen A, Tjonneland A, Overvad K, Raaschou-Nielsen O. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer. Cancer Lett. 2008;266(2):186–193. doi:10.1016/j.canlet.2008.02.046.
   PubMed Web of Science ®Google Scholar
• McKay JD, Hashibe M, Hung RJ, Wakefield J, Gaborieau V, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, et al. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe. Cancer Epidemiol Biomarkers Prev. 2008;17(1):141–147. doi:10.1158/1055-9965.EPI-07-0553.
   PubMed Web of Science ®Google Scholar
• LeMasters GK, Wilson K, Levin L, Biagini J, Ryan P, Lockey JE, Stanforth S, Maier S, Yang J, Burkle J, et al. High prevalence of aeroallergen sensitization among infants of atopic parents. J Pediatr. 2006;149(4):505–511.
   PubMed Web of Science ®Google Scholar
• Biagini Myers JM, Khurana Hershey GK, Deka R, Burkle JW, Levin LS, Bernstein DI, Villareal M, Lockey JE, Reponen T, Gareri J, et al. Asking the right questions to ascertain early childhood secondhand smoke exposures. J Pediatr. 2012;160(6):1050–1051. doi: S0022-3476(12)00243-0 [pii] doi:10.1016/j.jpeds.2012.02.040.
   PubMed Web of Science ®Google Scholar
• Reponen T, Vesper S, Levin L, Johansson E, Ryan P, Burkle J, Grinshpun SA, Zheng S, Bernstein DI, Lockey J, et al. High environmental relative moldiness index during infancy as a predictor of asthma at 7 years of age. Ann Allergy Asthma Immunol. 2011;107(2):120–126. doi:10.1016/j.anai.2011.04.018.
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program (NAEPP) NHLBI. expert panel report 3: guidelines for the diagnosis and management of asthma NIH Publication No. 07-4051. Bethesda, MD: National Heart, Lung and Blood Institute, 2007.
   Google Scholar
• Narayanaswarmy CR, Ragahavarao D. Principal component analysis of large dispersion matrices. J Royal Stat Soc. 1991;40(2):309–316.
   Google Scholar
• Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics. 2002;12(3):227–233.
   PubMedGoogle Scholar
• Yucesoy B, Kissling GE, Johnson VJ, Lummus ZL, Gautrin D, Cartier A, Boulet L-P, Sastre J, Quirce S, Tarlo SM, et al. N-acetyltransferase 2 genotypes are associated with diisocyanate-induced asthma. J Occup Environ Med. 2015;57(12):1331–1336. PubMed PMID: 26641831; doi:10.1097/JOM.0000000000000561.
   PubMed Web of Science ®Google Scholar
• Agency USEP. Health and environmental effects profile for methyl isocyanate. Cincinnati (OH): US Environmental Protection Agency; 1986.
   Google Scholar
• Kim J-M, Park B-L, Park S-M, Lee S-H, Kim M-O, Jung S, Lee EH, Uh S-T, Park JS, Choi J-S, et al. Association analysis of N-acetyl transferase-2 polymorphisms with aspirin intolerance among asthmatics. Pharmacogenomics. 2010;11(7):951–958. doi:10.2217/pgs.10.65.
   PubMed Web of Science ®Google Scholar
• Frieri M. Asthma concepts in the new millennium: update in asthma pathophysiology. Allergy Asthma Proc. 2005;26(2):83–88.
   PubMed Web of Science ®Google Scholar
• Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences. Clin Sci. 2005;108(6):463–477. doi:10.1042/cs20040342.
   PubMed Web of Science ®Google Scholar
• Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest. 1999;104(8):1001–1006. doi:10.1172/JCI8124.
   PubMed Web of Science ®Google Scholar
• Huber M, Muller J, Leier I, Jedlitschky G, Ball HA, Moore KP, Taylor GW, Williams R, Keppler D. Metabolism of cysteinyl leukotrienes in monkey and man. Eur J Biochem. 1990;194(1):309–315.
   PubMedGoogle Scholar
• Dairou J, Petit E, Ragunathan N, Baeza-Squiban A, Marano F, Dupret J-M, Rodrigues-Lima F. Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants. Toxicol Appl Pharmacol. 2009;236(3):366–371. doi:10.1016/j.taap.2009.02.010.
   PubMed Web of Science ®Google Scholar
• Gibson G. Human genetics. GTEx detects genetic effects. Science. 2015;348(6235):640–641. doi:10.1126/science.aab3002.
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(D1):D930–4. PubMed PMID: 22064851; doi:10.1093/nar/gkr917.
   PubMed Web of Science ®Google Scholar
• Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, Christiansen MW, Fairfax BP, Schramm K, Powell JE, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45(10):1238–1243. PubMed PMID: 24013639 doi:10.1038/ng.2756.
   PubMed Web of Science ®Google Scholar
• Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 1995;55(22):5230–5237.
   PubMed Web of Science ®Google Scholar
• Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 1995;55(22):5226–5229.
   PubMed Web of Science ®Google Scholar
• Zenser TV, Lakshmi VM, Rustan TD, Doll MA, Deitz AC, Davis BB, Hein DW. Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res. 1996;56(17):3941–3947.
   PubMed Web of Science ®Google Scholar
• Deitz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem. 1997;253(2):219–224. doi:10.1006/abio.1997.2379.
   PubMed Web of Science ®Google Scholar
• Cascorbi I, Roots I, Brockmoller J. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res. 2001;61(13):5051–5056.
   PubMed Web of Science ®Google Scholar
• Wikman H, Thiel S, Jäger B, Schmezer P, Spiegelhalder B, Edler L, Dienemann H, Kayser K, Schulz V, Drings P, et al. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics. 2001;11(2):157–168.
   PubMedGoogle Scholar